Moreover, thrombophilia tests (including testing for the factor-V-Leiden mutation, the G20210A prothrombin gene mutation, the JAK 2 mutation, protein C and S deficiency, and antithrombin deficiency) were carried out after the diagnosis of PVT and were negative. The gene discussed is JAK2; the disease is Rare hereditary thrombophilia.